Can a pill stop sleep disorder from turning into Parkinson's?
NCT ID NCT04534023
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug idebenone can slow or prevent the progression of a sleep disorder called iRBD into Parkinson's disease or similar brain conditions. About 142 adults aged 40-75 with iRBD will receive either idebenone or a placebo for 5 years. Researchers will track how many people develop Parkinson's or related diseases using questionnaires, blood tests, and brain scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartwatches and apps could spot dementia decades early
- Sleep study could unlock secrets of Parkinson's progression
- New study explores blood, skin, and nasal swabs to spot Parkinson's early
- Scientists probe body Clock's role in Dream-Acting sleep disorder
- Brain scan breakthrough: new tracer could catch Parkinson's early